Company Nanosonics Limited

Equities

NAN

AU000000NAN9

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Nanosonics Limited

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Delayed Australian S.E. Other stock markets 08:39:50 2024-04-23 pm EDT			5-day change	1st Jan Change
2.84 ^AUD	+1.07%		-0.70%	-35.23%

Mar. 15	Nanosonics Chief Technology Officer to Retire	MT
Feb. 26	Nanosonics Shares Fall 8% as H1 FY24 Revenue Falls 2% to AU$79.6 Million; EPS Slips to AU$0.0202	MT

Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (EPR). The Companyâs trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.

Number of employees: 482

AUD in Million	2022	Weight	2023	Weight	Delta
Consumables and Spare Parts 57.7 %	70	58.0 %	96	57.7 %	+37.23%
Healthcare Equipment 33.0 %	38	31.2 %	55	33.0 %	+45.98%
Service 10.2 %	12	10.3 %	17	10.2 %	+36.67%
Consumables and Service - Foreign Exchange Gain on Hedged Sales -0.5 %	0	0.4 %	-1	-0.5 %	-285.83%
Capital - Foreign Exchange Gain on Hedged Sales -0.4 %	0	0.1 %	-1	-0.4 %	-687.62%

AUD in Million	2022	Weight	2023	Weight	Delta
North America 90.6 %	107	88.9 %	150	90.6 %	+40.61%
Europe and Middle East 4.9 %	8	6.2 %	8	4.9 %	+8.38%
Asia Pacific 4.5 %	6	4.9 %	7	4.5 %	+27.50%

Managers	Title	Age	Since
Michael Kavanagh CEO	Chief Executive Officer	-	12-07-29
Jason Burriss DFI	Director of Finance/CFO	-	23-10-02
Sunny Pillai CIO	Chief Investment Officer	-	22-10-31
Rod Lopez COO	Chief Operating Officer	-	19-03-03
Steven Farrugia CTO	Chief Tech/Sci/R&D Officer	-	16-09-04
Matthew Lipscombe SAM	Sales & Marketing	-	-
Matthew Carbines LAW	General Counsel	-	-
Ines Klatt PRN	Corporate Officer/Principal	-	21-09-30
Gareth Daly AUD	Comptroller/Controller/Auditor	-	20-01-31
Jodi Sampson HRO	Human Resources Officer	-	20-03-31

Members of the board	Title	Age	Since
Larry Marshall BRD	Director/Board Member	-	23-10-02
David Fisher BRD	Director/Board Member	-	01-07-29
Steven Sargent CHM	Chairman	62	16-07-05
Michael Kavanagh CEO	Chief Executive Officer	-	12-07-29
Lisa McIntyre BRD	Director/Board Member	59	19-10-31
Geoff Wilson BRD	Director/Board Member	-	19-07-16
Marie McDonald BRD	Director/Board Member	68	16-10-23
Tracey Batten BRD	Director/Board Member	57	23-09-25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	302,829,367	252,571,745 ( 83.40 %)	0	83.40 %

Name	Equities	%	Valuation
Selector Funds Management Ltd. 7.318 %	22,167,173	7.318 %	40 M $
Maurie Stang 6.263 %	18,971,517	6.263 %	34 M $
First Sentier Investors (Australia) IM Ltd. 5.495 %	16,645,629	5.495 %	30 M $
ECP Asset Management Pty Ltd. 5.422 %	16,424,083	5.422 %	29 M $
Bernard Stang 5.392 %	16,333,493	5.392 %	29 M $
PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED 5.133 %	15,548,944	5.133 %	28 M $
AustralianSuper Pty Ltd. 4.976 %	15,071,273	4.976 %	27 M $
Fidelity Management & Research Co. LLC 4.561 %	13,816,275	4.561 %	25 M $
Steven Kritzler 2.143 %	6,489,737	2.143 %	12 M $
Australian Foundation Investment Co. Ltd. (Invt Mgmt) 1.932 %	5,853,377	1.932 %	11 M $

Nanosonics Ltd.

Macquarie Park 7-11 Talavera Road

2113, Sydney

+61 2 8063 1600

http://www.nanosonics.com.au

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2.81 AUD

Average target price

3.204 AUD

Spread / Average Target

+14.03%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NANOSONICS LIMITED	-36.14%	548M
THERMO FISHER SCIENTIFIC	+8.35%	209B
DANAHER CORPORATION	+9.41%	175B
INTUITIVE SURGICAL, INC.	+11.75%	131B
BOSTON SCIENTIFIC CORPORATION	+19.34%	99.98B
SIEMENS HEALTHINEERS AG	-0.84%	61.12B
EDWARDS LIFESCIENCES CORPORATION	+15.08%	52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-2.10%	46.5B
AGILENT TECHNOLOGIES, INC.	+0.10%	39.24B
GE HEALTHCARE TECHNOLOGIES INC.	+11.50%	38.47B

Other Advanced Medical Equipment & Technology